These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 658581)

  • 41. [Is it necessary to limit the use of the Copper-T-200 IUD to 3 years?].
    Curić F; Vuckovac M
    Jugosl Ginekol Opstet; 1979; 19(1-2):81-6. PubMed ID: 550021
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Ultra sonography for the localization of intra-uterine contraceptive devices (i.u.d.'s) (author's transl)].
    Meyenburg M
    Geburtshilfe Frauenheilkd; 1978 Nov; 38(11):950-7. PubMed ID: 710881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Nova-T and Copper-T in a 5 years' comparison].
    Nygren KG; Allonen H; Nielsen NC; Luukainen T; Pyörälä T
    Geburtshilfe Frauenheilkd; 1984 Mar; 44(3):180-4. PubMed ID: 6373482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Objective and subjective study of the copper-7 (author's transl)].
    Rochat P; Störi P
    Schweiz Rundsch Med Prax; 1978 May; 67(18):668-77. PubMed ID: 652725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intrauterine devices.
    Mccarthy TG; Ratnam SS
    Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The problem of contamination of copper bearing intrauterine devices (author's transl)].
    Feichter GE; Tauber PF; Rosenthal E; Ludwig H
    Geburtshilfe Frauenheilkd; 1978 Nov; 38(11):904-14. PubMed ID: 361496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The TCu380 IUD: initial international experimental results with the latest "T" family IUD].
    Elia D; Belaisch J
    Contracept Fertil Sex (Paris); 1985 Sep; 13(9):973-8. PubMed ID: 12267501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical experiences with the copper-T-intrauterine device (author's transl)].
    Zielske F; Felshart R; Hammerstein J
    Geburtshilfe Frauenheilkd; 1974 Jul; 34(7):525-39. PubMed ID: 4603400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Copper-7 IUD: clinicians, data support four years of use.
    Contracept Technol Update; 1985 Sep; 6(9):121-4. PubMed ID: 12267197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Postplacental application of 5 different types of intrauterine devices].
    Reynoso L; Arevalo N; Lara R; Aznar R
    Ginecol Obstet Mex; 1982 May; 50(301):107-10. PubMed ID: 7182224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-acting, more effective copper T IUDs: a summary of U.S. experience, 1970-75.
    Sivin I; Stern J
    Stud Fam Plann; 1979 Oct; 10(10):263-81. PubMed ID: 516121
    [No Abstract]   [Full Text] [Related]  

  • 53. [The behaviour of serum-coeruplasmin in women with intrauterine pessary containing copper (author's transl)].
    Tatra G; Beck A; Nikorovicz F
    Geburtshilfe Frauenheilkd; 1979 Jun; 39(6):487-91. PubMed ID: 478261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the Gravigard intrauterine copper contraceptive device.
    Macourt DC
    Med J Aust; 1974 May; 1(18):717-8. PubMed ID: 4851932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors affecting the clinical performance of Nova T and Copper T 200.
    Allonen H; Luukkainen T; Nielsen NC; Nygren KG; Pyörälä T
    Obstet Gynecol; 1984 Oct; 64(4):524-9. PubMed ID: 6384847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A fundamental study of copper-T (intrauterine device)].
    Murakami A; Murakami T; Tamaya T; Koyama M; Matsumoto T
    Nihon Funin Gakkai Zasshi; 1978 Jan; 23(1):33-5. PubMed ID: 627300
    [No Abstract]   [Full Text] [Related]  

  • 57. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Application of intrauterine devices preceded by measurement of the endometrial cavity using a Hollister sound].
    Reynoso Ron L; Lozano Balderas M; Lara Ricalde R; Flores Velez A; Aznar Ramos R
    Ginecol Obstet Mex; 1982 Feb; 50(298):21-4. PubMed ID: 7129181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Microscopic, micro-chemical and fluorescent optical findings in endometrium with a copper-T intrauterine device in situ (author's transl)].
    Dallenbach-Hellweg G; Dallenbach FD; Sievers S
    Geburtshilfe Frauenheilkd; 1979 Jul; 39(7):575-9. PubMed ID: 467951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cervical perforation due to a copper-T device placed following abortion (author's transl)].
    Wagner K; Quakernack K; Schmidt EH
    Geburtshilfe Frauenheilkd; 1976 Feb; 36(2):184-6. PubMed ID: 1254162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.